PRH-19070-50698
3 vaccinations
1 coded response
28 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 077 / NJ
- Registered
- 2021-08-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-26
Registered in v-safe
-
2021-08-26
Dose 1 — Pfizer-BioNTech
- 2021-08-26
- 2021-08-27
- 2021-08-28
- 2021-08-29
- 2021-08-30
- 2021-08-31
- 2021-09-01
- 2021-09-02
- 2021-09-09
-
2021-09-16
Dose 2 — Pfizer-BioNTech
- 2021-09-16
- 2021-09-16
-
2021-09-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-09-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-09-19
- 2021-09-20
- 2021-09-21
- 2021-09-22
- 2021-09-23
- 2021-09-30
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-12-16
-
2022-03-17
Dose 3 — Pfizer-BioNTech
- 2022-03-17
- 2022-05-04
- 2022-06-16
-
2023-03-17
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-26 | Pfizer-BioNTech | No |
| 2 | 2021-09-16 | Pfizer-BioNTech | No |
| 3 | 2022-03-17 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release